GF
Gates Foundation’s Vir Biotechnology VIR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $11.7M | Hold |
1,559,142
| – | – | 26.85% | 2 |
|
|
2024
Q2 | $13.9M | Hold |
1,559,142
| – | – | 34.5% | 1 |
|
|
2024
Q1 | $15.8M | Hold |
1,559,142
| – | – | 18.77% | 2 |
|
|
2023
Q4 | $15.7M | Hold |
1,559,142
| – | – | 17.45% | 3 |
|
|
2023
Q3 | $14.6M | Hold |
1,559,142
| – | – | 17.42% | 3 |
|
|
2023
Q2 | $38.2M | Hold |
1,559,142
| – | – | 30.44% | 1 |
|
|
2023
Q1 | $36.3M | Hold |
1,559,142
| – | – | 32.04% | 1 |
|
|
2022
Q4 | $39.5M | Hold |
1,559,142
| – | – | 30.41% | 1 |
|
|
2022
Q3 | $30.1M | Hold |
1,559,142
| – | – | 23.79% | 1 |
|
|
2022
Q2 | $39.7M | Hold |
1,559,142
| – | – | 30.52% | 1 |
|
|
2022
Q1 | $40.1M | Buy |
1,559,142
+881,365
| +130% | +$22.7M | 21.56% | 1 |
|
|
2021
Q4 | $28.4M | Hold |
677,777
| – | – | 8.62% | 6 |
|
|
2021
Q3 | $29.5M | Sell |
677,777
-2,100,000
| -76% | -$91.4M | 8.64% | 4 |
|
|
2021
Q2 | $131M | Hold |
2,777,777
| – | – | 20.13% | 3 |
|
|
2021
Q1 | $142M | Hold |
2,777,777
| – | – | 23.3% | 2 |
|
|
2020
Q4 | $74M | Buy |
+2,777,777
| New | +$74M | 16.9% | 3 |
|